FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044857579> ?p ?o ?g. }

• W2044857579 endingPage "29647" @default.
• W2044857579 startingPage "29643" @default.
• W2044857579 abstract "Previous studies have indicated that advanced age is associated with impaired angiogenesis in part because of reduced levels of vascular endothelial growth factor (VEGF) expression. To investigate potential mechanisms responsible for this age-dependent defect in VEGF expression, aortic smooth muscle cells isolated from young rabbits (ages 6–8 months) or old rabbits (ages 4–5 years) were exposed to normoxic (21% oxygen) or hypoxic (0.1% oxygen) conditions. Hypoxia-induced VEGF expression was significantly lower in old versus young cells. VEGF mRNA stability in hypoxic conditions was similar in both young and old cells. However, transient transfection with a luciferase reporter gene that was transcriptionally regulated by the VEGF promoter revealed a significant defect in VEGF up-regulation following hypoxia in oldversus young cells (a 43 versus 117% increase in luciferase activity, p < 0.05); this difference was not seen when a deletion construct lacking the hypoxia-inducible 1 (HIF-1) binding site was used. Moreover, although HIF-1α-mRNA expression was shown to be similar in young and old smooth muscle cells, HIF-1α protein and DNA binding activity were significantly reduced in old versus young smooth muscle cells that were exposed to hypoxia. We propose that age-dependent reduction in hypoxia-induced VEGF expression results from reduced HIF-1 activity and may explain the previously described age-dependent impairment of angiogenesis in response to ischemia. Previous studies have indicated that advanced age is associated with impaired angiogenesis in part because of reduced levels of vascular endothelial growth factor (VEGF) expression. To investigate potential mechanisms responsible for this age-dependent defect in VEGF expression, aortic smooth muscle cells isolated from young rabbits (ages 6–8 months) or old rabbits (ages 4–5 years) were exposed to normoxic (21% oxygen) or hypoxic (0.1% oxygen) conditions. Hypoxia-induced VEGF expression was significantly lower in old versus young cells. VEGF mRNA stability in hypoxic conditions was similar in both young and old cells. However, transient transfection with a luciferase reporter gene that was transcriptionally regulated by the VEGF promoter revealed a significant defect in VEGF up-regulation following hypoxia in oldversus young cells (a 43 versus 117% increase in luciferase activity, p < 0.05); this difference was not seen when a deletion construct lacking the hypoxia-inducible 1 (HIF-1) binding site was used. Moreover, although HIF-1α-mRNA expression was shown to be similar in young and old smooth muscle cells, HIF-1α protein and DNA binding activity were significantly reduced in old versus young smooth muscle cells that were exposed to hypoxia. We propose that age-dependent reduction in hypoxia-induced VEGF expression results from reduced HIF-1 activity and may explain the previously described age-dependent impairment of angiogenesis in response to ischemia. vascular endothelial growth factor hypoxia-inducible factor 1 erythropoietin vascular smooth muscle cell enzyme-linked immunosorbent assay electromobility shift assay base pair(s) One of the characteristics of aging is the decline in the ability of the organism to respond to different types of stress. For instance, we have recently demonstrated that advanced age is associated with a defect in compensatory neovascularization in response to tissue ischemia (1Rivard A. Fabre J.E. Silver M. Chen D. Murohara T. Kearney M. Magner M. Asahara T. Isner J.M. Circulation. 1999; 99: 111-120Crossref PubMed Scopus (647) Google Scholar). Such impaired angiogenesis in ischemic tissues of old animals was found to be associated with reduced expression of vascular endothelial growth factor (VEGF),1 an endothelial-specific growth factor that is essential for embryonic (2Carmeliet P. Ferreira V. Breier G. Pollefeyt S. Kieckens L. Gertsenstein M. Fahrig M. Vandenhoeck A. Harpal K. Eberhardt C. Declercq C. Pawling J. Moons L. Collen D. Risau W. Nagy A. Nature. 1996; 380: 435-439Crossref PubMed Scopus (3475) Google Scholar,3Ferrara N. Carver-Moore K. Chen H. Dowd M. Lu L. O'Shea K. Powell-Braxton L. Hilan K.J. Moore M.W. Nature. 1996; 380: 439-442Crossref PubMed Scopus (3061) Google Scholar) and postnatal (4Ferrara N. Davis-Smyth T. Endocr. Rev. 1997; 18: 4-25Crossref PubMed Scopus (3668) Google Scholar) neovascularization. The molecular alterations responsible for this age-dependent decline in VEGF expression, however, have not been elucidated. Among those factors that have been implicated in the regulation of VEGF expression, hypoxia appears to play a major role, both in vitro (5Shweiki D. Itin A. Soffer D. Keshet E. Nature. 1992; 359: 843-845Crossref PubMed Scopus (4176) Google Scholar) and in vivo (6Banai S. Shweiki D. Pinson A. Chandra M. Lazarovici G. Keshet E. Cardiovasc. Res. 1994; 28: 1176-1179Crossref PubMed Scopus (412) Google Scholar). The transcriptional and post-transcriptional mechanisms involved in the hypoxic regulation of VEGF are similar to those factors responsible for erythropoietin (Epo) expression. Transcriptional regulation of VEGF expression at the 5′-promoter of VEGF is conferred by a sequence that is homologous to the hypoxia-inducible factor 1 (HIF-1) binding site within the Epo gene (7Levy A.P. Levy N.S. Wegner S. Goldberg M.A. J. Biol. Chem. 1995; 270: 13333-13340Abstract Full Text Full Text PDF PubMed Scopus (879) Google Scholar). HIF-1 is a heterodimeric (HIF-1α and HIF-1β) basic helix-loop-helix protein that activates the transcription of the Epo gene in hypoxic cells (8Wang G.L. Jiang B.H. Rue E.A. Semenza G.L. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 5510-5514Crossref PubMed Scopus (5103) Google Scholar). When reporter genes containing VEGF sequences are co-transfected with expression vectors that encode HIF-1α and HIF-1β, the reporter gene transcription is much higher in both hypoxic and normoxic cells than in cells transfected with the reporter gene alone (9Forsythe J.A. Jiang B.H. Iyer N.V. Agani F. Leung S.W. Koos R.D. Semenza G.L. Mol. Cell. Biol. 1996; 16: 4604-4613Crossref PubMed Scopus (3232) Google Scholar). Moreover, the results of gene-targeting experiments have shown that HIF-1α deficiency is associated with a complete loss of VEGF gene induction under hypoxic conditions, marked reduction in vascularization of embryos, and early lethality by embryonic day 10.5 (10Iyer N.V. Kotch L.E. Agani F. Leung S.W. Laughner E. Wenger R.H. Gassmann M. Gearhart J.D. Lawler A.M., Yu, A.Y. Semenza G.L. Genes Dev. 1998; 12: 149-162Crossref PubMed Scopus (2068) Google Scholar). In this study, we used an in vitro system to investigate potential transcriptional and post-transcriptional mechanisms involved in the age-dependent defect of VEGF induction by hypoxia. Our results indicate that the reduction in VEGF expression with aging is primarily attributed to a lower transcriptional activity under hypoxic conditions. Thus, this lower transcriptional activity is related to an age-dependent defect in HIF-1 activity. Cultures of primary vascular smooth muscle cells (VSMCs) were isolated from the aortas of young New Zealand White rabbits (ages 6–8 months) or old New Zealand White rabbits (ages 4–5 years) as described by Mader (11Mader S.L. J. Gerontol. Biol. Sci. 1992; 47: B32-B36Crossref Scopus (26) Google Scholar). The maximum age for New Zealand White rabbits was previously reported to be 7 years (12Weisbroth S. Weisbroth S. Flatt H. Kraus A. Neoplastic Diseases. Academic Press, New York1974: 331Google Scholar). Cells were incubated in Dulbecco's modified of Eagle's medium (Sigma), supplemented with 10% fetal bovine serum, 2 mml-glutamine, 200 units/ml penicillin, and 0.25 mg/ml streptomycin. Cells were cultured at 37 °C in a humidified atmosphere of normoxic conditions (5% CO2, 21% O2, and 74% N2), or placed in a modular incubator chamber (Billups-Rothenberg, New York), flushed with hypoxic gas (95% N2 and 5% CO2), and incubated at 37 °C in a humidified atmosphere. All experiments were performed with early passage (P1-P3) rabbit VSMCs at 70% confluence. VSMCs from young and old rabbits were incubated under normoxic or hypoxic conditions for a 24-h period. The supernatant was collected and VEGF levels were determined by using an immunoassay according to the manufacturer's instructions (Quantikine, R&D Systems). Results were compared with a standard curve of human VEGF with a lower detection limit of 5 pg/ml. Samples were checked by serial dilution and were performed at least in duplicate. VEGF levels were normalized relative to the protein concentration of VSMC cellular extracts (Bio-Rad protein assay). VSMCs (P1) from young and old rabbits were incubated under normoxic or hypoxic conditions for a 24-h period, washed with phosphate-buffered saline, and lysed in lysis buffer. Total protein extracts were quantified with the Bio-Rad protein assay. The protein extract (100 μg per sample) was separated on a 4–12% polyacrylamide gel (Bio-Rad) and electroblotted on a nitrocellulose membrane. The membrane was blocked with 10% nonfat dry milk in 0.2% Tween phosphate-buffered saline and then probed with VEGF rabbit polyclonal antibody (1:200 dilution, Santa Cruz Biotechnology, Inc.), an HIF-1α mouse monoclonal antibody (1:400 dilution, Novus Biologicals), or an actin goat polyclonal antibody (1:200 dilution, Santa Cruz) for 2 h at room temperature. The membrane was washed three times in Tween phosphate-buffered saline and then incubated with anti-rabbit (1:7000), anti-mouse (1:5000), or anti-goat (1:2000) horseradish peroxidase IgG for 1 h. Antigen-antibody complexes were visualized after incubation for 1 min with enhanced luminescence reagent (Amersham Pharmacia Biotech) at room temperature, followed by exposure to hyperfilms (Amersham Pharmacia Biotech). Each experiment was repeated at least twice with different cellular extracts. Representative results are shown below. Total cellular RNA was isolated from VSMCs by acid guanidinium phenol/chloroform extraction (13Chomczynski P. Sacchi N. Anal. Biochem. 1987; 162: 156-159Crossref PubMed Scopus (63231) Google Scholar). The total denatured RNA (15 μg) was subjected to electrophoresis in a 1.0% agarose/formaldehyde gel and then transferred to a nylon membrane (Hybond-N, Amersham Pharmacia Biotech). A 675-bpEcoRI/BglII fragment of pSVI.VEGF.21 (14Brogi E. Wu T. Namiki A. Isner J.M. Circulation. 1994; 90: 649-652Crossref PubMed Scopus (537) Google Scholar), or a 345-bp fragment of human HIF-1α cDNA (pBluescript/HIF-1α 3.2–3T7) (8Wang G.L. Jiang B.H. Rue E.A. Semenza G.L. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 5510-5514Crossref PubMed Scopus (5103) Google Scholar) were used as specific probes. All probes were radio-labeled by random-primed labeling (Rediprime kit, Amersham Pharmacia Biotech). Filters were hybridized overnight with 106 cpm/ml of the probe and then washed in 0.5 × SSC,0.1% SDS for 10 min at room temperature, twice for 30 min at 65 °C, and subsequently exposed to Kodak XAR-5 films. For VEGF mRNA stability studies, VSMCs were exposed to hypoxic conditions for 24 h before the addition of 5 μg/ml actinomycin D to block gene transcription. RNA isolation was performed at different time-points (0, 1, 2, and 3 h). Subsequently, VEGF mRNA was analyzed by Northern blot and by densitometric analysis of the autoradiograms that were exposed in the linear range of film density using a Hewlett-Packard scanner with National Institutes of Health Image Software. Least squares regression analysis of the resulting lines was performed, and half-life values were determined from the regression curves. Each experiment was repeated at least twice with different cell extracts. Representative results are shown below. For transfection experiments, we used a reporter construct containing the luciferase gene under the transcriptional control of the VEGF promoter (a 2.3 kilobase pair KpnI/NheI fragment of VEGF 5′-promoter region). From this initial full-length reporter gene, a deletion construct lacking the HIF-1 binding site was generated by restriction endonuclease digestion, PstI, as described previously (9,15). VSMCs were transiently transfected with 10 μg of reporter construct and with 30 μg of LipofectAMINE reagent (Life Technologies, Inc.). After transfection, VSMCs were allowed to recover for 3 h in Dulbecco's modified Eagle's medium, supplemented with 10% fetal bovine serum before exposure to normoxic or hypoxic conditions. To correct for differences in transfection efficiency, luciferase activity was normalized relative to the level of alkaline phosphatase activity that was produced from co-transfected pSVAPAP plasmid (0.5 μg), which contained the reporter gene under the control of the simian virus 40 enhancer-promoter. The cells were incubated with the transfection mixture for 3 h and then exposed to normoxic or hypoxic conditions. After 24 h, luciferase and alkaline phosphatase activities were measured in the VSMCs in old and young rabbits. Results are expressed as the ratio of luciferase to alkaline phosphatase activities. Cells were plated on four-well chamber slides before being exposed to either normoxic or hypoxic culture conditions for 6 h. Cells were fixed in 10% neutral buffered formalin for 10 min before staining. They were then incubated in 3% hydrogen peroxide to block endogenous peroxidase and 10% horse serum as a protein block before overnight incubation with the monoclonal HIF-1α antibody (1:5000 dilution). Signal amplification and detection were then carried out using the peroxidase-Catalyzed Signal Amplification System (Dako, Carpinteria, CA) according to the manufacturer's instructions (16Zhong H. De Marzo A.M. Laughner E. Lim M. Hilton D.A. Zagzag D. Buechler P. Isaacs W.B. Semenza G.L. Simons J.W. Cancer Res. 1999; 59: 5830-5835PubMed Google Scholar). Finally, the reaction product was visualized by incubation with 0.05% (w/v) 3,3′-diaminobenzidine tetrahydrochloride dihydrate, and a counterstain of 10% Gill hematoxylin was applied before cover-slipping. EMSA was performed in a buffer containing 10 mm Tris-HCl (pH 7.5), 4% glycerol, 1 mm MgCl2, 0.5 mm EDTA, 0.5 mm dithiothreitol, 50 mm NaCl, and 0.05 mg/ml poly(dI·dC)/poly(dI·dC). After 10 min of preincubation in ice, 20 μg of whole cell extracts were incubated for 30 min with 1 pmol (4 × 104 cpm) of 32P-labeled double-stranded oligonucleotide probe spanning the VEGF HIF-1 binding site (5′-TGCATACGTGGGCTCCAACAG-3′; HIF-1 site isunderlined) (9Forsythe J.A. Jiang B.H. Iyer N.V. Agani F. Leung S.W. Koos R.D. Semenza G.L. Mol. Cell. Biol. 1996; 16: 4604-4613Crossref PubMed Scopus (3232) Google Scholar). Unlabeled oligonucleotide was added to the preincubation mixture for competition assays (50-fold molar excess). Binding reactions were performed with a final volume of 15 μl (20 μg of cell extract), separated at 4 °C in non-denaturing 4% acrylamide gels in 0.5 × TBE-running buffer. Each condition was performed in duplicate. The gel was dried and exposed to Kodak XAR-5 films. To study the effect of aging on VEGF expression in vitro, VSMCs that were isolated from young or old rabbits were exposed to normoxic or hypoxic conditions for 24 h, and the VEGF expression was evaluated at mRNA and protein levels. As shown in Fig. 1 A, VEGF mRNA levels were low and similar among young and old VSMCs under normoxic conditions. VEGF levels were significantly increased by hypoxia in both groups. However, the magnitude of VEGF induction by hypoxia in old VSMCs (157% increase versus normoxia) was significantly lower than that of young VSMCs (273% increase versusnormoxia). Similar findings were observed at the protein level. VEGF levels in the supernatant ELISA were low and similar among young and old VSMCs in normoxic conditions (Fig. 1 B). Although VEGF values were significantly higher in both young and old VSMCs under hypoxic conditions, the magnitude of VEGF induction was significantly reduced in old versus young VSMCs (100 versus213% induction by hypoxia). This finding was confirmed by Western blot experiments on cellular extracts from VSMCs, which were exposed to hypoxic conditions. As seen in Fig. 1 C, VEGF levels were significantly reduced in old versus young hypoxic VSMCs. These results indicate that aging impairs VEGF induction under hypoxic conditions. Because VEGF expression is regulated not only at the transcriptional level but post-transcriptionally as well (15Ikeda E. Achen M.G. Breier G. Risau W. J. Biol. Chem. 1995; 270: 19761-19766Abstract Full Text Full Text PDF PubMed Scopus (538) Google Scholar), we investigated whether VEGF mRNA half-life under hypoxic conditions was reduced by aging. VSMCs were exposed to hypoxic conditions for 24 h before the addition of 5 μg/ml actinomycin D to block gene transcription. RNA isolation was performed at different time-points, and the VEGF- mRNA half-life was determined after Northern blotting. As shown in Fig. 2, no significant difference in mRNA half-life was found between young and old VSMCs (2.4 versus 2.8 h, p = not significant), indicating that the age-dependent impairment of VEGF induction under hypoxic conditions is not because of a decrease in mRNA stability. To investigate whether the transcriptional regulation of VEGF is affected by aging, we transfected VSMCs that were isolated from young or old rabbits with a reporter construct containing the luciferase gene under the transcriptional control of the VEGF promoter. The cells were then exposed to hypoxic conditions for a 24-h period, and promoter activities were measured in young and old VSMCs (Fig.3). VEGF promoter activity achieved under hypoxia in old VSMCs was almost half of that in young VSMCs (2.1 ± 0.3 versus 3.9 ± 0.1, p < 0.01). However, when a promoter construct lacking the HIF-1 binding site (Pst, Fig. 3), was transfected instead of the full-length reporter gene, VEGF promoter activity was not increased from hypoxia and no significant difference was found between the young and old VSMCs. This finding implicates HIF-1α in the age-dependent defect of VEGF induction by hypoxia. Next, we evaluated HIF-1α expression at the mRNA and protein levels in young and old VSMCs (Fig. 4). HIF-1α mRNA was not up-regulated by hypoxia, and similar levels were found in young and old VSMCs under normoxic or hypoxic conditions (Fig.4 A). At the protein level, HIF-1α expression was barely detectable under normoxic conditions. Under hypoxic conditions, HIF-1α protein expression was observed in young VSMCs, P1, but was reduced in old VSMCs (Fig. 4 B). HIF-1α immunostaining likewise disclosed reduced expression of HIF-1α protein in oldversus young VSMCs that were exposed to 6 h of hypoxia (Fig. 4 C). To study the effect of aging on HIF-1α DNA binding activity, we used a probe to span the VEGF HIF-1 binding site, and we performed electromobility shift assays on protein extracts from young or old VSMCs (Fig. 5). No specific HIF-1 DNA binding activity could be detected under normoxic conditions in either young or old VSMCs. Under hypoxic conditions, HIF-1 DNA-binding activity was observed in young VSMCs but was still undetectable in old VSMCs. In this study, we have identified HIF-1 as a major factor involved in the age-dependent impairment of VEGF expression. We first confirmed in vitro the previously described reduction of VEGF expression in ischemic tissues of old animals (1Rivard A. Fabre J.E. Silver M. Chen D. Murohara T. Kearney M. Magner M. Asahara T. Isner J.M. Circulation. 1999; 99: 111-120Crossref PubMed Scopus (647) Google Scholar). Reduced VEGF expression in VSMCs that were isolated from old animals was seen only in hypoxic versus normoxic conditions at both the mRNA and protein levels. This indicates that aging is associated with a defect in VEGF up-regulation under hypoxic conditions. Hypoxia-stimulated VEGF expression has been attributed to increases in both transcriptional and post-transcriptional mechanisms (15Ikeda E. Achen M.G. Breier G. Risau W. J. Biol. Chem. 1995; 270: 19761-19766Abstract Full Text Full Text PDF PubMed Scopus (538) Google Scholar, 16Zhong H. De Marzo A.M. Laughner E. Lim M. Hilton D.A. Zagzag D. Buechler P. Isaacs W.B. Semenza G.L. Simons J.W. Cancer Res. 1999; 59: 5830-5835PubMed Google Scholar, 17Levy A.P. Levy N.S. Goldberg M.A. J. Biol. Chem. 1996; 271: 25492-25497Abstract Full Text Full Text PDF PubMed Scopus (207) Google Scholar, 18Levy A.P. Levy N.S. Goldberg M.A. J. Biol. Chem. 1996; 271: 2746-2753Abstract Full Text Full Text PDF PubMed Scopus (560) Google Scholar, 19Shima D.T. Deutsch U. D'Amore P.A. FEBS Lett. 1995; 370: 203-208Crossref PubMed Scopus (281) Google Scholar, 20Stein I. Neeman M. Shweiki D. Itin A. Keshet E. Mol. Cell. Biol. 1995; 15: 5363-5368Crossref PubMed Scopus (416) Google Scholar, 21Frenkel-Denkberg G. Gershon D. Levy A.P. FEBS Lett. 1999; 462: 341-344Crossref PubMed Scopus (101) Google Scholar, 22Shih S.C. Claffey K.P. J. Biol. Chem. 1999; 274: 1359-1365Abstract Full Text Full Text PDF PubMed Scopus (185) Google Scholar). Previous investigators have demonstrated the central role of hypoxia in transcriptional up-regulation of VEGF expression (14Brogi E. Wu T. Namiki A. Isner J.M. Circulation. 1994; 90: 649-652Crossref PubMed Scopus (537) Google Scholar, 23Ryan H.E. Lo J. Johnson R.S. EMBO J. 1998; 17: 3005-3015Crossref PubMed Scopus (1340) Google Scholar). In this study, transfection experiments with a reporter gene under the control of the VEGF promoter clearly demonstrate that aging is associated with a reduction in hypoxia-induced VEGF transcriptional activity. Importantly, the age-dependent reduction in transcriptional activity was not seen when VSMCs were transfected with a reporter construct lacking the HIF-1 binding site. HIF-1 is a transcription factor that is known to be involved in several physiological responses to hypoxia. These responses are mediated by specific genes that are transcriptionally induced by HIF-1, such as the genes for glycolytic enzymes (24Semenza G.L. Jiang B.H. Leung S.W. Passantino R. Concordet J.P. Maire P. Giallongo A. J. Biol. Chem. 1996; 271: 32529-32537Abstract Full Text Full Text PDF PubMed Scopus (1376) Google Scholar), erythropoietin (25Goldberg M.A. Schneider T.J. J. Biol. Chem. 1994; 269: 4355-4359Abstract Full Text PDF PubMed Google Scholar, 26Bunn H.F. Gu J. Huang L.E. Park J.W. Zhu H. J. Exp. Biol. 1998; 201: 1197-1201PubMed Google Scholar), and VEGF (9, 25 ). HIF-1 has been shown to be essential for VEGF transcriptional activation, both in vitro (9Forsythe J.A. Jiang B.H. Iyer N.V. Agani F. Leung S.W. Koos R.D. Semenza G.L. Mol. Cell. Biol. 1996; 16: 4604-4613Crossref PubMed Scopus (3232) Google Scholar) and in vivo (10Iyer N.V. Kotch L.E. Agani F. Leung S.W. Laughner E. Wenger R.H. Gassmann M. Gearhart J.D. Lawler A.M., Yu, A.Y. Semenza G.L. Genes Dev. 1998; 12: 149-162Crossref PubMed Scopus (2068) Google Scholar). Using 5′-flanking sequences mediating transcriptional activation of reporter gene expression, for example, Forsythe et al. (9Forsythe J.A. Jiang B.H. Iyer N.V. Agani F. Leung S.W. Koos R.D. Semenza G.L. Mol. Cell. Biol. 1996; 16: 4604-4613Crossref PubMed Scopus (3232) Google Scholar) showed that a 47-bp sequence located at 985 to 939 bp 5′ to the VEGF transcription initiation site was necessary for VEGF induction in hypoxic Hep3B cells. A HIF-1 binding site was demonstrated in the 47-bp response element, and a 3-bp substitution eliminated the ability of the element to bind HIF-1 and activate transcription in response to hypoxia. Moreover, the results of gene-targeting experiments have shown that HIF-1 null mice fail to up-regulate VEGF expression under hypoxic conditions, leading to a marked reduction in vascularization of the developing embryo and early lethality by embryonic day 10.5 (10Iyer N.V. Kotch L.E. Agani F. Leung S.W. Laughner E. Wenger R.H. Gassmann M. Gearhart J.D. Lawler A.M., Yu, A.Y. Semenza G.L. Genes Dev. 1998; 12: 149-162Crossref PubMed Scopus (2068) Google Scholar). Collectively, these data confirm the essential role of HIF-1 in VEGF induction under hypoxic conditions. In this study, we found that HIF-1α mRNA levels were not induced by hypoxia and were similar among young and old VSMCs. This finding is consistent with a previous study in which HIF-1α and HIF-1β mRNAs are shown to be constitutively expressed in HeLa and Hep3B cells with no significant induction by hypoxia. In fact, the activation of HIF-1 by hypoxia is shown to be primarily determined by the stabilization of HIF-1α protein (27Huang L.E. Arany Z. Livingston D.M. Bunn H.F. J. Biol. Chem. 1996; 271: 32253-32259Abstract Full Text Full Text PDF PubMed Scopus (1025) Google Scholar). Our analysis of HIF-1α protein expression under hypoxic conditions suggested that the stabilization of HIF-1α was impaired with aging. The exact mechanisms involved in this age-dependent reduction of HIF-1α protein expression are unknown. HIF-1α protein has been shown to be rapidly degraded by the ubiquitin-protease system under normoxic conditions and stabilized by hypoxia through redox-induced changes (28Salceda S. Caro J. J. Biol. Chem. 1997; 272: 22642-22647Abstract Full Text Full Text PDF PubMed Scopus (1417) Google Scholar, 29Huang L.E. Gu J. Schau M. Bunn H.F. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 7987-7992Crossref PubMed Scopus (1855) Google Scholar, 30Kallio P.J. Wilson W.J. O'Brien S. Makino Y. Poellinger L. J. Biol. Chem. 1999; 274: 6519-6525Abstract Full Text Full Text PDF PubMed Scopus (694) Google Scholar). Whether these mechanisms are affected by aging remains to be determined. Increase in mRNA stability constitutes a second important control point for the hypoxic induction of VEGF in different cell lines (15Ikeda E. Achen M.G. Breier G. Risau W. J. Biol. Chem. 1995; 270: 19761-19766Abstract Full Text Full Text PDF PubMed Scopus (538) Google Scholar,19Shima D.T. Deutsch U. D'Amore P.A. FEBS Lett. 1995; 370: 203-208Crossref PubMed Scopus (281) Google Scholar). Stabilization of VEGF mRNA by hypoxia is thought to be mediated by the binding of sequence-specific RNA-binding proteins (21Frenkel-Denkberg G. Gershon D. Levy A.P. FEBS Lett. 1999; 462: 341-344Crossref PubMed Scopus (101) Google Scholar,22Shih S.C. Claffey K.P. J. Biol. Chem. 1999; 274: 1359-1365Abstract Full Text Full Text PDF PubMed Scopus (185) Google Scholar) to the sequences in both the 3′- and 5′-untranslated region of VEGF mRNA (18Levy A.P. Levy N.S. Goldberg M.A. J. Biol. Chem. 1996; 271: 2746-2753Abstract Full Text Full Text PDF PubMed Scopus (560) Google Scholar). Our findings indicated that VEGF mRNA half-life under hypoxic conditions was similar in VSMCs that were isolated from young and old animals. This finding suggests that the mechanisms involved in VEGF mRNA stabilization by hypoxia are not compromised with aging. The results of EMSA in the current experiments indicated that DNA binding activity of HIF-1 under hypoxic conditions was significantly reduced in VSMCs that were isolated from old animals. Whether this was solely because of a reduction of HIF-1α protein expression is unclear. It is also possible that aging leads to a reduction in the ability of HIF-1 to bind to the hypoxia response element within the VEGF promoter, or that the ability of HIF-1α to form active heterodimers is reduced. Such post-translational loss of function has previously been described with aging for other proteins (31Reiss U. Gershon D. Eur. J. Biochem. 1976; 63: 617-623Crossref PubMed Scopus (153) Google Scholar, 32Gershon H. Gershon D. Proc. Natl. Acad. Sci. U. S. A. 1973; 70: 909-913Crossref PubMed Scopus (165) Google Scholar) and transcription factors (33Riabowol K. Schiff J. Gilman M.Z. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 157-161Crossref PubMed Scopus (183) Google Scholar, 34Roy A.K. Mol. Med. 1997; 3: 496-504Crossref PubMed Google Scholar). The current findings implicate age-dependent defects in HIF-1 activity as being primarily responsible for reduced expression of VEGF and impaired angiogenesis associated with aging (1Rivard A. Fabre J.E. Silver M. Chen D. Murohara T. Kearney M. Magner M. Asahara T. Isner J.M. Circulation. 1999; 99: 111-120Crossref PubMed Scopus (647) Google Scholar). HIF-1 is also involved in the induction of other genes, including Epo and glycolytic enzymes. Reduced expression of metabolic and biosynthetic genes has been reported in association with advanced aging (35Lee C.K. Klopp R.G. Weindruch R. Prolla T.A. Science. 1999; 285: 1390-1393Crossref PubMed Scopus (1283) Google Scholar). Similarly, lower secretion of Epo has been observed in old animals (36Wang R.Y. Tsai S.C. Lu C.C. Shih H.C. Chen Y.H. Tung Y.F. Wang W.F. Wang S.W. Wang P.S. J. Gerontol. A Biol. Sci. Med. Sci. 1996; 51: B434-B438Crossref PubMed Scopus (14) Google Scholar) and in elderly patients (37Nafziger J. Pailla K. Luciani L. Andreux J.P. Saint-Jean O. Casadevall N. Am. J. Hematol. 1993; 43: 172-176Crossref PubMed Scopus (33) Google Scholar, 38Ribatti D. Presta M. Vacca A. Ria R. Giuliani R. Dell'Era P. Nico B. Roncali L. Dammacco F. Blood. 1999; 93: 2627-2636Crossref PubMed Google Scholar). The findings of this study thus suggest that an age-dependent defect in HIF-1 action could result in a reduction in the expression of genes that are directly involved in the physiological responses to hypoxia." @default.
• W2044857579 created "2016-06-24" @default.
• W2044857579 creator A5042650571 @default.
• W2044857579 creator A5042848023 @default.
• W2044857579 creator A5051276665 @default.
• W2044857579 creator A5058992043 @default.
• W2044857579 creator A5075023515 @default.
• W2044857579 creator A5081595718 @default.
• W2044857579 creator A5082589573 @default.
• W2044857579 creator A5084445039 @default.
• W2044857579 date "2000-09-01" @default.
• W2044857579 modified "2023-09-29" @default.
• W2044857579 title "Age-dependent Defect in Vascular Endothelial Growth Factor Expression Is Associated with Reduced Hypoxia-inducible Factor 1 Activity" @default.
• W2044857579 cites W1536635467 @default.
• W2044857579 cites W1576953405 @default.
• W2044857579 cites W1583148430 @default.
• W2044857579 cites W174559571 @default.
• W2044857579 cites W1858064340 @default.
• W2044857579 cites W189180901 @default.
• W2044857579 cites W1964037605 @default.
• W2044857579 cites W1966932577 @default.
• W2044857579 cites W1967244780 @default.
• W2044857579 cites W1985712533 @default.
• W2044857579 cites W1991843895 @default.
• W2044857579 cites W1993011693 @default.
• W2044857579 cites W2001718129 @default.
• W2044857579 cites W2010394923 @default.
• W2044857579 cites W2015344488 @default.
• W2044857579 cites W2025974453 @default.
• W2044857579 cites W2037835822 @default.
• W2044857579 cites W2038449972 @default.
• W2044857579 cites W2038750685 @default.
• W2044857579 cites W2045247659 @default.
• W2044857579 cites W2056242981 @default.
• W2044857579 cites W2061834490 @default.
• W2044857579 cites W2075054245 @default.
• W2044857579 cites W2085609942 @default.
• W2044857579 cites W2093498435 @default.
• W2044857579 cites W2098972920 @default.
• W2044857579 cites W2100272171 @default.
• W2044857579 cites W2104525623 @default.
• W2044857579 cites W2107689453 @default.
• W2044857579 cites W2109492293 @default.
• W2044857579 cites W2110603899 @default.
• W2044857579 cites W2125450897 @default.
• W2044857579 cites W2163069245 @default.
• W2044857579 cites W2165081949 @default.
• W2044857579 cites W2324258416 @default.
• W2044857579 cites W4294216491 @default.
• W2044857579 doi "https://doi.org/10.1074/jbc.m001029200" @default.
• W2044857579 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10882714" @default.
• W2044857579 hasPublicationYear "2000" @default.
• W2044857579 type Work @default.
• W2044857579 sameAs 2044857579 @default.
• W2044857579 citedByCount "275" @default.
• W2044857579 countsByYear W20448575792012 @default.
• W2044857579 countsByYear W20448575792013 @default.
• W2044857579 countsByYear W20448575792014 @default.
• W2044857579 countsByYear W20448575792015 @default.
• W2044857579 countsByYear W20448575792016 @default.
• W2044857579 countsByYear W20448575792017 @default.
• W2044857579 countsByYear W20448575792018 @default.
• W2044857579 countsByYear W20448575792019 @default.
• W2044857579 countsByYear W20448575792020 @default.
• W2044857579 countsByYear W20448575792021 @default.
• W2044857579 countsByYear W20448575792022 @default.
• W2044857579 countsByYear W20448575792023 @default.
• W2044857579 crossrefType "journal-article" @default.
• W2044857579 hasAuthorship W2044857579A5042650571 @default.
• W2044857579 hasAuthorship W2044857579A5042848023 @default.
• W2044857579 hasAuthorship W2044857579A5051276665 @default.
• W2044857579 hasAuthorship W2044857579A5058992043 @default.
• W2044857579 hasAuthorship W2044857579A5075023515 @default.
• W2044857579 hasAuthorship W2044857579A5081595718 @default.
• W2044857579 hasAuthorship W2044857579A5082589573 @default.
• W2044857579 hasAuthorship W2044857579A5084445039 @default.
• W2044857579 hasBestOaLocation W20448575791 @default.
• W2044857579 hasConcept C103041312 @default.
• W2044857579 hasConcept C104317684 @default.
• W2044857579 hasConcept C126322002 @default.
• W2044857579 hasConcept C134018914 @default.
• W2044857579 hasConcept C146285616 @default.
• W2044857579 hasConcept C15215337 @default.
• W2044857579 hasConcept C160450060 @default.
• W2044857579 hasConcept C167734588 @default.
• W2044857579 hasConcept C170493617 @default.
• W2044857579 hasConcept C178790620 @default.
• W2044857579 hasConcept C185592680 @default.
• W2044857579 hasConcept C2775960820 @default.
• W2044857579 hasConcept C2777025900 @default.
• W2044857579 hasConcept C2909350873 @default.
• W2044857579 hasConcept C502942594 @default.
• W2044857579 hasConcept C540031477 @default.
• W2044857579 hasConcept C55493867 @default.
• W2044857579 hasConcept C71924100 @default.
• W2044857579 hasConcept C7836513 @default.
• W2044857579 hasConcept C86339819 @default.
• W2044857579 hasConcept C86803240 @default.

• next